482 related articles for article (PubMed ID: 29018889)
21. Oculocutaneous albinism: epidemiology, genetics, skin manifestation, and psychosocial issues.
Ma EZ; Zhou AE; Hoegler KM; Khachemoune A
Arch Dermatol Res; 2023 Mar; 315(2):107-116. PubMed ID: 35217926
[TBL] [Abstract][Full Text] [Related]
22. Clinical and mutational characteristics of oculocutaneous albinism type 7.
Kruijt CC; de Wit GC; van Minderhout HM; Schalij-Delfos NE; van Genderen MM
Sci Rep; 2024 Mar; 14(1):7572. PubMed ID: 38555393
[TBL] [Abstract][Full Text] [Related]
23. The Molecular Basis of Chemical Chaperone Therapy for Oculocutaneous Albinism Type 1A.
Teramae A; Kobayashi Y; Kunimoto H; Nakajima K; Suzuki T; Tsuruta D; Fukai K
J Invest Dermatol; 2019 May; 139(5):1143-1149. PubMed ID: 30447237
[TBL] [Abstract][Full Text] [Related]
24. Ophthalmic features of minimal pigment oculocutaneous albinism.
Summers CG; King RA
Ophthalmology; 1994 May; 101(5):906-14. PubMed ID: 8190479
[TBL] [Abstract][Full Text] [Related]
25. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
Oetting WS; King RA
Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
[TBL] [Abstract][Full Text] [Related]
26. Mutation analysis of a Chinese family with oculocutaneous albinism.
Wang X; Zhu Y; Shen N; Peng J; Wang C; Liu H; Lu Y
Oncotarget; 2016 Dec; 7(51):84981-84988. PubMed ID: 27829221
[TBL] [Abstract][Full Text] [Related]
27. Albinism and the associated ocular defects.
Oetting WS; Summers CG; King RA
Metab Pediatr Syst Ophthalmol (1985); 1994; 17(1-4):5-9. PubMed ID: 8719278
[TBL] [Abstract][Full Text] [Related]
28. In silico analysis of miRNA-mediated gene regulation in OCA and OA genes.
Kamaraj B; Gopalakrishnan C; Purohit R
Cell Biochem Biophys; 2014 Dec; 70(3):1923-32. PubMed ID: 25060099
[TBL] [Abstract][Full Text] [Related]
29. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism.
Lee ST; Nicholls RD; Bundey S; Laxova R; Musarella M; Spritz RA
N Engl J Med; 1994 Feb; 330(8):529-34. PubMed ID: 8302318
[TBL] [Abstract][Full Text] [Related]
30. Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism.
Onojafe IF; Adams DR; Simeonov DR; Zhang J; Chan CC; Bernardini IM; Sergeev YV; Dolinska MB; Alur RP; Brilliant MH; Gahl WA; Brooks BP
J Clin Invest; 2011 Oct; 121(10):3914-23. PubMed ID: 21968110
[TBL] [Abstract][Full Text] [Related]
31. Biallelic mutations in L-dopachrome tautomerase (DCT) cause infantile nystagmus and oculocutaneous albinism.
Volk AE; Hedergott A; Preising M; Rading S; Fricke J; Herkenrath P; Nürnberg P; Altmüller J; von Ameln S; Lorenz B; Neugebauer A; Karsak M; Kubisch C
Hum Genet; 2021 Aug; 140(8):1157-1168. PubMed ID: 33959807
[TBL] [Abstract][Full Text] [Related]
32. Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism.
King RA; Townsend D; Oetting W; Summers CG; Olds DP; White JG; Spritz RA
J Clin Invest; 1991 Mar; 87(3):1046-53. PubMed ID: 1900307
[TBL] [Abstract][Full Text] [Related]
33. Albinism and its implications with vision.
Kirkwood BJ
Insight; 2009; 34(2):13-6. PubMed ID: 19534229
[TBL] [Abstract][Full Text] [Related]
34. Ocular findings and a comparative study of hair, skin and iris color in Chinese patients with albinism.
Arcot Sadagopan K; Teng CH; Hui G; Lin DL
Ophthalmic Genet; 2023 Feb; 44(1):54-69. PubMed ID: 36316991
[TBL] [Abstract][Full Text] [Related]
35. Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4.
Newton JM; Cohen-Barak O; Hagiwara N; Gardner JM; Davisson MT; King RA; Brilliant MH
Am J Hum Genet; 2001 Nov; 69(5):981-8. PubMed ID: 11574907
[TBL] [Abstract][Full Text] [Related]
36. Identification of a missense mutation in the tyrosinase gene in a Chinese family with oculocutaneous albinism type 1.
Lu Q; Yuan L; Xu H; Huang X; Yang Z; Yi J; Ni B; Chen Y; Deng H
Mol Med Rep; 2017 Mar; 15(3):1426-1430. PubMed ID: 28112372
[TBL] [Abstract][Full Text] [Related]
37. Clinical utility gene card for oculocutaneous (OCA) and ocular albinism (OA)-an update.
Aamir A; Kuht HJ; Grønskov K; Brooks BP; Thomas MG
Eur J Hum Genet; 2021 Oct; 29(10):1577-1583. PubMed ID: 33504991
[No Abstract] [Full Text] [Related]
38. Genetics of non-syndromic and syndromic oculocutaneous albinism in human and mouse.
Fernández A; Hayashi M; Garrido G; Montero A; Guardia A; Suzuki T; Montoliu L
Pigment Cell Melanoma Res; 2021 Jul; 34(4):786-799. PubMed ID: 33960688
[TBL] [Abstract][Full Text] [Related]
39. Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism.
King RA; Mentink MM; Oetting WS
Mol Biol Med; 1991 Feb; 8(1):19-29. PubMed ID: 1943686
[TBL] [Abstract][Full Text] [Related]
40. Genetic Causes of Oculocutaneous Albinism in Pakistani Population.
Sajid Z; Yousaf S; Waryah YM; Mughal TA; Kausar T; Shahzad M; Rao AR; Abbasi AA; Shaikh RS; Waryah AM; Riazuddin S; Ahmed ZM
Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33800529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
